Proliferation antigen Ki-67 (Gerdes et al, 1991) is a biomarker of tumour activity, and an adverse prognostic factor in patients with IDC (Fitzgibbons et al, 2000; Jung et al, 2009). The gene discussed is MKI67; the disease is neoplasm.